Natus Medical Incorporated Buyback
OLI recorded this information on 2/22/2018
Natus Medical Incorporated
Natus Medical Incorporated (NASDAQ:BABY) announced that its Board of Directors has authorized the repurchase of up to $30 million of the Company's common stock. The expiration date is set for February 26, 2019.
Natus Medical is a provider of neurology, newborn care, and hearing and balance assessment healthcare products and services. Co. has three business units: Neuro, which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery; Newborn Care, which includes products and services for newborn care including hearing screening, brain injury, retinopathy of prematurity vision screening, thermoregulation, jaundice management, and various disposable newborn care supplies; and Otometrics, which includes products for hearing and diagnostics and hearing aid fitting, including computer-based audiological.
Open the BABY Page at The Online Investor »
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite